Page 4 - Nasdaq Stro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sutro Biopharma (NASDAQ:STRO – Free Report) and Codiak BioSciences (NASDAQ:CDAK – Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations. Profitability This table compares Sutro Biopharma and Codiak BioSciences’ […]

- Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab...

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Rating) have received a consensus rating of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year […]

Sutro Biopharma (NASDAQ:STRO – Get Rating) and Voyager Therapeutics (NASDAQ:VYGR – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, earnings, risk and dividends. Institutional and Insider Ownership 87.6% of Sutro Biopharma shares […]

Sutro Biopharma (NASDAQ:STRO – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Valuation & Earnings This table compares Sutro Biopharma and […]